AATec Medical
Unlocking the therapeutic potential of AAT
A drug platform based on alpha-1 antitrypsin
We develop therapeutics based on alpha-1 antitrypsin (AAT) for the treatment of diseases of high medical need with global societal impact
Alpha-1 antitrypsin
AAT is a natural human immuno-modulator, regulating pro-inflammatory enzymes
Significant therapeutic potential in auto-immune and infectious diseases, AAT deficiency and other conditions
Favourable safety profile, well-investigated
Technology
Large-scale recombinant manufacturing of human AAT
Inhalative application using state-of-the-art inhaler technology
Drug platform for broad range of indications
Our therapeutics address widespread virus infections, auto-immune diseases and rare conditions such as AAT deficiency and ARDS.
We develop therapeutic solutions for respiratory virus diseases such as corona, influenza and RSV infections, to support global efforts to prepare for future pathogen threats.
We enable large-scale AAT manufacturing through cutting-edge recombinant technology. We utilize state-of-the-art inhaler technology and other technologies for safe, effective and convenient AAT drug administration.
Our aim is to provide patient-centric drugs for diseases highly relevant at global level. Accessible, affordable and with worldwide reach.
management
CEO
Experienced executive in biotech & health tech, strategic advisor for start-up companies, PhD in biochemistry
Chief Scientific Officer
Chief physician for organ transplant, founder of Apceth and JunctuCell, MD
Chief Medical Officer
Chief physician for hand surgery, founder of JunctuCell, MD
ADvisory Board
Chairman of the Board
Former CEO of the BSH Home Appliances Group, non-executive director, mentor & advisor
Board Member
Former global executive at Philips, NXP, G&D, secunet, VC partner and founder
Board Member
Partner, Sträter Lawyers. Health legislation in Germany and the European Union
Scientific Advisory Board
Director, Institute of Virology at TU Munich and Director, Institute of Virology at Helmholtz Center Munich
AATec News & Updates
